יחס מחיר להכנסות חזויות: Impact BioMedical, Inc. (IBO)

Impact BioMedical Inc conducts research on botanical extracts in the US, which determines the dynamics of the future P/S metric. Capitalization is based on patent royalties, although the dispersion of resources creates margin risks. The current status is 1016.10, while this chart demonstrates the current balance of supply and demand, helping to assess the degree of undervaluation or the weakness of this asset.

The forward P/S ratio determines the market value of the business relative to expected annual sales, allowing for an assessment of capitalization sensitivity to potential cash gaps. By analyzing the history of the forward P/S valuation, an investor can correlate the growth rates of Impact BioMedical Inc (IBO) with the success of Linebacker antiseptic licensing and the rigor of FDA inspections affecting the company's future revenue.